The anti-human CCR9 mAb 92R, which recognizes the human CCR9, but not the mouse CCR9, inhibits the growth of subcutaneous xenografts generated with the human T-ALL cell line MOLT-4 (35). This evidence concerns the gene CCR9 and acute lymphoblastic leukemia.